Atorvastatin Calcium
Product Images NDC 70934-614

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 614 90 Master Bottle Label Approval Rev A 06 20)

Label (70934 614 90 Master Bottle Label Approval Rev A 06 20)
This is a medication description for Atorvastatin Calcium Tablets with a strength of 20 mg, supplied in a bottle of 90 tablets. The manufacturer is Retend Uastsone and the NDC code is 70934-614-90. The other information is not legible or does not appear to be relevant.*
FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

Atorvastatin-fig-1 (Atorvastatin Fig 1)
FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

Atorvastatin-fig-2 (Atorvastatin Fig 2)
This is a graph showing the Cumulative Hazard over four years of follow-up for two treatments: Placebo and Atorvastatin. The Hazard for Atorvastatin is lower than the hazard for Placebo at every point in time, and the Hazard Ratio is found to be 0.63 with a p-value of 0.001.*
FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

Atorvastatin-fig-3 (Atorvastatin Fig 3)
The given text represents data related to subjects who experienced major cardiovascular events (%) while taking different doses of Atorvastatin over a period of time. The event occurrence was significantly lower among subjects taking Atorvastatin 80 mg as compared to those on 10 mg dose. The hazard ratio and p-value further establish the effectiveness of Atorvastatin 80mg in lowering the risk of major cardiovascular events. The time to the first major cardiovascular endpoint is also shown in years.*
FDA Label Image

Atorvastatin-st (Atorvastatin St)

Atorvastatin-st (Atorvastatin St)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.